Upregulation of Reg 1alpha and GW112 in the Epithelium of Inflamed Colonic Mucosa

Overview

Journal Gut

Specialty Gastroenterology

Date 2001 Apr 17

PMID 11302958

Citations 43

Authors

S Shinozaki

T Nakamura

M Iimura

Y Kato

B Iizuka

M Kobayashi

N Hayashi

Affiliations

Soon will be listed here.

Abstract

Background And Aims: Colonic epithelium is involved in the regulation of intestinal function and mucosal immune responses, and its function is altered in inflammatory bowel disease (IBD). However, a comprehensive analysis of the genetic alterations in inflamed colonic epithelium is not available at present. The aim of our study was to detect genes that are preferentially expressed in inflamed colonic epithelia and clarify the biochemical responses of epithelial cells in inflamed colonic mucosa.

Methods: cDNA representation difference analysis was used to identify candidate genes selectively expressed in inflamed colonic epithelia. Selective expression of these genes in the epithelium of inflamed colonic mucosa, including IBD and non-IBD tissues, was examined by real time polymerase chain reaction and in situ hybridisation. The effect of cell confluence and inflammatory mediators on Reg 1alpha gene expression was examined using a colon cancer cell line (HT29).

Results: We identified seven candidate genes that were presumed to be upregulated in the inflamed colonic epithelium. Of these, Reg 1alpha and GW112 were the dominant species and expression of these genes was confined to the crypt epithelium. In vitro studies using a colonic epithelial cell line suggested that cell confluence regulates Reg 1alpha gene expression.

Conclusions: Selective expression of Reg 1alpha and GW112 genes in the crypt epithelium of inflamed colonic mucosa suggests the important regulatory functions of these genes.

Citing Articles

Apolipoprotein E ε4-Specific Relationship Between Serum Olfactomedin 4 and Alzheimer's Disease.

Wei C, Zhang G, Fu X, Zhao M, Zhai W, Shen Y Mol Neurobiol. 2025; .

PMID: 40055292 DOI: 10.1007/s12035-025-04812-w.

OLFM4 modulates intestinal inflammation by promoting IL-22ILC3 in the gut.

Xing Z, Li X, He J, Chen Y, Zhu L, Zhang X Commun Biol. 2024; 7(1):914.

PMID: 39075283 PMC: 11286877. DOI: 10.1038/s42003-024-06601-y.

Intranasal Nose-to-Brain Drug Delivery via the Olfactory Region in Mice: Two In-Depth Protocols for Region-Specific Intranasal Application of Antibodies and for Expression Analysis of Fc Receptors via In Situ Hybridization in the Nasal Mucosa.

Herzog H, Glockler S, Flamm J, Ladel S, Maigler F, Pitzer C Methods Mol Biol. 2024; 2754:387-410.

PMID: 38512678 DOI: 10.1007/978-1-0716-3629-9_21.

Olfactomedin-4 deletion exacerbates DSS-induced colitis through a matrix metalloproteinase-9-dependent mechanism.

Wang X, Chen S, Wang J, Chen Y, Guo Y, Wang Q Int J Biol Sci. 2023; 19(7):2150-2166.

PMID: 37151883 PMC: 10158032. DOI: 10.7150/ijbs.80441.

A primary cell-based model of the human small intestine reveals host olfactomedin 4 induction in response to Typhimurium infection.

Daullary T, Imdahl F, Dietrich O, Hepp L, Krammer T, Fey C Gut Microbes. 2023; 15(1):2186109.

PMID: 36939013 PMC: 10038062. DOI: 10.1080/19490976.2023.2186109.

References

Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y . A novel gene activated in regenerating islets. J Biol Chem. 1988; 263(5):2111-4. View

Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162(1):156-9. DOI: 10.1006/abio.1987.9999. View

Watanabe T, Yonekura H, Terazono K, Yamamoto H, Okamoto H . Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene. J Biol Chem. 1990; 265(13):7432-9. View

Rouquier S, Verdier J, Iovanna J, Dagorn J, Giorgi D . Rat pancreatic stone protein messenger RNA. Abundant expression in mature exocrine cells, regulation by food content, and sequence identity with the endocrine reg transcript. J Biol Chem. 1991; 266(2):786-91. View

Figarella C, Amouric M, Bertrand C, Balas D . Immunocytochemical demonstration of a pancreatic secretory protein of unknown function in human duodenum. J Histochem Cytochem. 1991; 39(7):915-9. DOI: 10.1177/39.7.1865108. View

Sadlack B, Merz H, Schorle H, Schimpl A, Feller A, Horak I . Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 1993; 75(2):253-61. DOI: 10.1016/0092-8674(93)80067-o. View

Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W . Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993; 75(2):263-74. DOI: 10.1016/0092-8674(93)80068-p. View

Watanabe T, Yonemura Y, Yonekura H, Suzuki Y, Miyashita H, Sugiyama K . Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci U S A. 1994; 91(9):3589-92. PMC: 43625. DOI: 10.1073/pnas.91.9.3589. View

Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang H, Reed J . Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol. 1994; 145(6):1323-36. PMC: 1887502. View

10.

Hubank M, Schatz D . Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 1994; 22(25):5640-8. PMC: 310128. DOI: 10.1093/nar/22.25.5640. View

11.

Woywodt A, Neustock P, Kruse A, Schwarting K, Ludwig D, Stange E . Cytokine expression in intestinal mucosal biopsies. In situ hybridisation of the mRNA for interleukin-1 beta, interleukin-6 and tumour necrosis factor-alpha in inflammatory bowel disease. Eur Cytokine Netw. 1994; 5(4):387-95. View

12.

Owen D, Kelly J . Inflammatory diseases of the gastrointestinal tract. Mod Pathol. 1995; 8(1):97-108. View

13.

Hermiston M, Gordon J . Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 1995; 270(5239):1203-7. DOI: 10.1126/science.270.5239.1203. View

14.

Gibson P, Rosella O . Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut. 1995; 37(4):536-43. PMC: 1382907. DOI: 10.1136/gut.37.4.536. View

15.

Heid C, Stevens J, Livak K, Williams P . Real time quantitative PCR. Genome Res. 1996; 6(10):986-94. DOI: 10.1101/gr.6.10.986. View

16.

Zgraggen K, Walz A, Mazzucchelli L, Strieter R, Mueller C . The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology. 1997; 113(3):808-16. DOI: 10.1016/s0016-5085(97)70175-6. View

17.

Toy L, Yio X, Lin A, Honig S, Mayer L . Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest. 1997; 100(8):2062-71. PMC: 508397. DOI: 10.1172/JCI119739. View

18.

Ortiz E, Dusetti N, Vasseur S, Malka D, Bodeker H, Dagorn J . The pancreatitis-associated protein is induced by free radicals in AR4-2J cells and confers cell resistance to apoptosis. Gastroenterology. 1998; 114(4):808-16. DOI: 10.1016/s0016-5085(98)70595-5. View

19.

Sakai T, Kusugami K, Nishimura H, Ando T, Yamaguchi T, Ohsuga M . Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology. 1998; 114(6):1237-43. DOI: 10.1016/s0016-5085(98)70430-5. View

20.

Panja A, Goldberg S, Eckmann L, Krishen P, Mayer L . The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol. 1998; 161(7):3675-84. View